期刊文献+

PET在头颈肿瘤中的应用 被引量:4

The Clinical Application of PET in Diagnosis and Treatment of Head and Neck Tumors
下载PDF
导出
摘要 正电子发射型计算机断层显像(Positron Emission Tomography,简称PET)是用解剖形态学方式进行功能、代谢和受体显像并提供分子水平信息的一项前沿医学科学显像诊断技术。它主要利用构成人体基本元素的超短半衰期同位素如氧(O)、氮(N)、碳(C)、氟(F)等示踪生命的基本物质代谢过程,具有灵敏度高、创伤性小等特点,可在分子水平上反映人体生理或病理变化。目前临床常用的显象剂主要是氟脱氧葡萄糖(FDG),它主要反映人体葡萄糖代谢过程。PET在肿瘤学方面的临床应用可以追溯到20世纪80年代。早期的PET主要应用于不明确的孤立性肺部结节的诊断方面。随着其技术的不断完善、检查辅助药物制备成本下降和优越性的体现,PET的临床应用被逐渐推广至大肠、食管、乳腺和头颈部等肿瘤的诊断、分期和疗效监测、复发或残余病灶的检出等方面,本文就其在头颈部肿瘤中的应用予以综述。 Positron emission tomography (Positron Emission Tomography, i.e. PET in brief) is a technique of medical localization diagnosis in frontier science that conducts functional, metabolic and receptor visualization with anatomic morphology and provides information of molecular level. It mainly utilize the primary substance metabolism process of the hyper-short-half-life isotope, which compose the human essential elements, such as O, N, C and F, etc. It has the characteristics of high sensitivity and minor trauma and can reflect physiological or pathological changes of humans at molecular level, At present, the fluorodeoxyglucose (FDG), a common developer used in clinical practice can mainly re- flect human metabolic process of glucose. The clinical application of PET in oncology can be traced back to 1980's. Early application of PET has mainly been in diagnosis of indefinite and solitary nodus of the lung. With consummation of the technology, decrement of cost for examining preparation of anciliary drugs and materialization of the superiority, the clinical application of PET were gradually extended to the diagnosis, staging and surveiliance of curative effects, as well as detection of relapse or residual foci for tumors in large intestine, esophagus, breast, and head and neck, ere.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第17期1018-1020,共3页 Chinese Journal of Clinical Oncology
基金 四川省医学重点学科建设项目基金资助(编号:20020807)
关键词 PET 头颈肿瘤 诊断 PET Head and neck tumor Diagnosis
  • 相关文献

参考文献13

  • 1Kole AC,Nieweg OE,Pruim J,et al.Detection of unknown occult primary tumors using positron emission tomography[J].Cancer,1998,82(6):1160~1166 被引量:1
  • 2AAssar OS,Fischbein NJ,Caputo GR,et al.Metastatic head and neck cancer:role and usefulness of FDG PET in locating occult primary tumors[J].Radiology,1999,210(1):177~ 181 被引量:1
  • 3Kresnik E,Mikosch P,Gallowitsch HJ,et al.Evaluation of head and neck cancer with 18F-FDG PET:a comparison with conventional modalities[J].Eur J Nucl Med,2001,28(7):816~821 被引量:1
  • 4de Geus-Oei LF,Pieters GF,Bonenkamp JJ,et al.18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results[J].2006,47(5):770~775 被引量:1
  • 5李超,陈建超,王朝晖.新旧头颈肿瘤TNM分期系统的比较与分析[J].国际耳鼻咽喉头颈外科杂志,2006,30(1):62-64. 被引量:4
  • 6Greven KM,Williams DW,3rd,McGuirt WF,Sr,et al.Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer[J].Head Neck,2001,23(11):942~946 被引量:1
  • 7Nowak B,Di Martino E,Janicke S,et al.Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI[J].Nuklearmedizin,1999,389(8):312~318 被引量:1
  • 8Manolidis S,Donald PJ,Volk P,et al.The use of positron emission tomography scanning in occult and recurrent head and neck cancer[J].Acta Otolaryngol Suppl,1998,534:1~11 被引量:1
  • 9Li P,Zhuang H,Mozley PD,et al.Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography[J].Clin Nucl Med,2001,26(2):131 ~ 135 被引量:1
  • 10Lonneux M,Lawson G,Ide C,et al.Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in symptomatic patients[J].Laryngoscope,2000,110(9):1493~1497 被引量:1

二级参考文献9

共引文献3

同被引文献27

  • 1关中,彭解人,黄晓明,蔡翔中,许耀东,龚坚中.胸大肌皮瓣修复喉咽癌术后组织缺损[J].中华显微外科杂志,2004,27(4):300-301. 被引量:16
  • 2李超,陈建超,王朝晖.新旧头颈肿瘤TNM分期系统的比较与分析[J].国际耳鼻咽喉头颈外科杂志,2006,30(1):62-64. 被引量:4
  • 3李超,陈建超,王朝晖,孙维刚,王影.头颈部鳞癌安全手术切缘的评价[J].中华口腔医学杂志,2006,41(8):478-480. 被引量:13
  • 4Silver HJ, Dietrich MS, Murphy BA. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy [J]. Head Neck, 2007, 29(10) :893 -900. 被引量:1
  • 5Horwitz SB. Mechanism of action of taxol [ J ]. Treds Biochem Sci, 1992,13 (21 ) : 1342 - 1345. 被引量:1
  • 6Shin DM, Lippman SM. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions[ J]. Semin Oncol, 1999, 26 (23) : 100 - 105. 被引量:1
  • 7Hussain M, Salwen W, Kucuk O, et al. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report [J]. Semin Oncol, 1997,24(6) :43 -45. 被引量:1
  • 8Cmelak A J, Murphy BA, Burkey B, et al. Taxane-based chemoirradiation for organ preservation with locally advanced head and neckcancer: results of a phase Ⅱ multi-institutional trial [ J ]. Head Neck, 2007,29(4) :315 -324. 被引量:1
  • 9Malone JP, Stephens JA, Grecula JC, et al. Disease control, survival, and functional outcome after muhimodal treatment for advanced-stage tongue base cancer [ J]. Head Neck, 2004,26 (7) :561 -572. 被引量:1
  • 10黄海欣,李桂生,黄东宁,宁四海,王占宇.不同化疗方案配合放疗治疗局部晚期鼻咽癌的临床观察[J].中国肿瘤临床,2007,34(16):947-948. 被引量:6

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部